Companies: 10,305     total market cap: NZ$200.923 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Eli Lilly
LLY
#13
Rank
NZ$1.250 T
Marketcap
🇺🇸 United States
Country
$1,390
Share price
-1.38%
Change (1 day)
51.78%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

Eli Lilly (LLY) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$55.23 Billion

According to Eli Lilly's latest financial reports the company's total debt is NZ$55.23 Billion. A company’s total debt is the sum of all current and non-current debts.

Eli Lilly - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$39.88 B55.96%
2022-12-31NZ$25.57 B3.47%
2021-12-31NZ$24.71 B7.48%
2020-12-31NZ$22.99 B1.13%
2019-12-31NZ$22.74 B48.13%
2018-12-31NZ$15.35 B-20.1%
2017-12-31NZ$19.21 B29.16%
2016-12-31NZ$14.87 B27.62%
2015-12-31NZ$11.65 B13.87%
2014-12-31NZ$10.23 B61.39%
2013-12-31NZ$6.34 B-5.66%
2012-12-31NZ$6.72 B-24.89%
2011-12-31NZ$8.95 B-0.29%
2010-12-31NZ$8.97 B-2.12%
2009-12-31NZ$9.17 B-49.12%
2008-12-31NZ$18.02 B175.79%
2007-12-31NZ$6.53 B24%
2006-12-31NZ$5.27 B-44.55%
2005-12-31NZ$9.50 B4.17%
2004-12-31NZ$9.12 B21.47%
2003-12-31NZ$7.51 B-19.81%
2002-12-31NZ$9.36 B13.82%
2001-12-31NZ$8.23 B29.46%
2000-12-31NZ$6.35 B8.84%
1999-12-31NZ$5.84 B30.09%
1998-12-31NZ$4.49 B2.06%
1997-12-31NZ$4.40 B-16.63%
1996-12-31NZ$5.27 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Bristol-Myers Squibb
BMY
NZ$91.22 B 65.17%🇺🇸 USA
Merck
MRK
NZ$67.67 B 22.53%🇺🇸 USA
Johnson & Johnson
JNJ
NZ$63.45 B 14.88%🇺🇸 USA
Pfizer
PFE
NZ$118.23 B 114.07%🇺🇸 USA
Sanofi
SNY
NZ$45.19 B-18.18%🇫🇷 France
GlaxoSmithKline
GSK
NZ$38.14 B-30.94%🇬🇧 UK
AbbVie
ABBV
NZ$126.15 B 128.41%🇺🇸 USA
Amgen
AMGN
NZ$107.20 B 94.08%🇺🇸 USA
Novartis
NVS
NZ$57.07 B 3.34%🇨🇭 Switzerland
AstraZeneca
AZN
NZ$56.01 B 1.42%🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com